Article Versions Notes

Zhang Y, Darville L, Hogue S, Hallanger Johnson JE, Rose T, Kim Y, Bailey A, Gray JE, Robinson LA. High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer. Cancers. 2024; 16(6):1152. https://doi.org/10.3390/cancers16061152

Zhang, Yumeng, Lancia Darville, Stephanie Hogue, Julie E. Hallanger Johnson, Trevor Rose, Youngchul Kim, Alexis Bailey, Jhanelle E. Gray, and Lary A. Robinson. 2024. "High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer" Cancers 16, no. 6: 1152. https://doi.org/10.3390/cancers16061152

Zhang, Y., Darville, L., Hogue, S., Hallanger Johnson, J. E., Rose, T., Kim, Y., Bailey, A., Gray, J. E., & Robinson, L. A. (2024). High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer. Cancers, 16(6), 1152. https://doi.org/10.3390/cancers16061152